Miami-based Gastro Health is setting a bold new course in GI care, driven by physician engagement and growth strategies.
Category: Gastroenterology and Endoscopy
The next growth opportunity for outpatient GI
The capsule endoscopy market has shown significant growth in recent years due to the increased prevalence of gastrointestinal disorders and the growing preference for non-invasive diagnostic procedures, according to a recent market report.
The workforce trends keeping gastroenterologists up at night
Gastroenterologists are watching closely as shifts in the healthcare workforce are poised to reshape their field in the coming years.
Maryland gastroenterology practice closes after 30 years
Hagerstown, Md.-based Gastroenterology Associates closed Jan. 21 after more than 30 years of practice, according to a notice posted on the practice’s Facebook page.
Peterson Health opens GI clinic
Kerrville, Texas-based Peterson Health has opened a new GI clinic at the Amanda and J. David Williams Surgery Center, which opened its doors in June 2024, according to a Feb. 17 report from the Hill Country Community Journal.
The hurdles arising from the CRC screening boom
Colorectal cancer screenings are booming, a trend driven largely by revised guidelines recommending screenings begin at age 45, as well as the lingering backlog of elective endoscopy cases from the COVID-19 pandemic.
Gastroenterologists vs. red tape
From Stark law to prior authorization hurdles, gastroenterologist leaders see three major regulatory obstacles stifling industry growth and innovation.
Gastroenterologists vs. red tape
From Stark law to prior authorization hurdles, gastroenterologist leaders see three major regulatory obstacles stifling industry growth and innovation.
UC Davis Health earns colorectal surgery accreditation
UC Davis (Calif.) Health’s colorectal surgery program has been designated a surgical quality partner by the American College of Surgeons and the National Accreditation Program for Rectal Cancer.
GLP-1s and colonoscopy: 3 notes
The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of Gastroenterology.
